On Wednesday, Haleon (NYSE: HLN), the consumer healthcare company, said it will invest $54 million in its global research and development center in Richmond, U.S., aiming to boost its pipeline for new product innovations.
The company said the investment is in addition to its 300 million pounds ($372.5 million) annual spending in R&D.
The Richmond facility is one of the three R&D centers of excellence for Haleon, along with Weybridge, UK, and Suzhou, China.
($1 = 0.8053 pounds)
Maria Reed is a financial journalist with a passion for covering US equities. She joined the ABBO News team in June 2023. Maria holds an M.S. degree in International Economics and Finance from Otto-von-Guericke University in Magdeburg and is a CFA Level 2 candidate. Read Full Bio
